ProDeg™ BICALUTAMIDE, Target protein ligand (Protein Degrader) (CAT#: PRLG-016)
Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Specifications |
|---|
| Product Description |
Bicalutamide is a non-steroidal anti-androgen that binds to the ligand-binding domain of the androgen receptor, competitively inhibiting androgen action. It serves as a warhead for bifunctional molecules mediating AR degradation. |
| Molecular Formula |
C18H14F4N2O4S |
| Molecular Weight (Da) |
430.4 |
| Chemical Name |
N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide |
| Chemical Structure |
 |
| Purity |
0.99 |
| Size |
5 mg |
| Physical State |
Powder |
| Storage |
The power can be stored at 4 °C for 2 years or at -20 °C for 3 years. |
| Target Information |
|---|
| Target Name |
AR |
| Alternative Names |
AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM |
| Introduction |
AR is a nuclear receptor transcription factor containing an N-terminal transactivation domain, a central DNA-binding domain with two zinc fingers, and a C-terminal ligand-binding domain. Upon androgen binding, it translocates to the nucleus and regulates target gene expression. |
| Gene ID |
367 |
| UniProt ID |
P10275 |
| Related Disease |
Prostate cancer, androgen insensitivity syndrome, spinal bulbar muscular atrophy |
Our services are For Research Use Only. We do not provide direct services for patients.
